Ovarian response, embryo production and hormonal profile in superovulated goats treated with insulin.

The influence of insulin on ovarian response and embryo production was investigated in 30 mixed breed goats, divided randomly into three equal (n=10) groups. Goats in Group 1 (control) were superovulated using 20 IU FSH i.m. in six divided descending doses, i.e. 4/4, 3/3 and 3/3 IU at 12 h interval for three consecutive days and were not given insulin treatment. Goats in Group 2 (insulin pretreatment) were pretreated with long acting purified bovine insulin 0.2 IU/kg body weight per day s.c. on Days 7, 8 and 9 of the estrous cycle prior to initiation of superovulatory treatment as in Group 1. Animals in Group 3 (insulin cotreatment) were treated as in Group I, but in addition received long acting purified bovine insulin 0.2 IU/kg body weight per day s.c. as a cotreatment along with the first, third and fifth FSH treatments on three consecutive days. Total ovarian response (corpus luteum and unovulated large follicle (UOLF)) was significantly (P<0.05) higher in insulin pretreatment (17.90+/-3.08) than in the cotreatment (11.50+/-2.34) and control (11.90+/-1.87) groups. The number of UOLF was significantly higher (P<0.05) in the insulin pretreatment (10.2+/-1.67) than the cotreatment (4.9+/-1.14) and control (3.6+/-1.09) groups. The mean transferable quality of embryos did not differ significantly among treatments. Progesterone concentration on the day of PGF(2)alpha treatment was not different (P>0.05) between the insulin treatment groups (5.28+/-0.79; 5.30+/-0.66 ng/ml). Estradiol-17beta concentration was significantly (P<0.05) higher on the day of PGF(2)alpha treatment in both the insulin treatment groups (36.67+/-6.40; 34.33+/-4.33 pg/ml) as compared to the control group (20.00+/-2.73 pg/ml). There is ample evidence to indicate beneficial effect of insulin on folliculogenesis and steroidogenesis in superovulated goats.

Fertility responses and hormonal profiles in repeat breeding cows treated with insulin.

The influence of insulin treatment on conception rate and endocrine profile was studied on 21 repeat breeding cows divided randomly into two groups, i.e. insulin treatment (n = 11) and control (n = 10). Cows of the insulin treatment group were injected subcutaneously with a long acting purified form of bovine insulin at 0.2 IU/kg body weight/day on days 8, 9 and 10, and then with 0.75 mg tiaprost (PGF(2)alpha) intramuscularly on day 12 of the oestrous cycle (oestrus = day 0). The cows of the control group only received 0.75 mg tiaprost was injected intramuscularly on day 12. There was no difference (P > 0.05) in the interval to the onset of oestrus and subsequent cycle length between the treatment (84.5 +/- 6.6 h and 21.2 +/- 0.6 days, respectively) and the control (72.3 +/- 5.9 h and 19.7 +/- 0.4 days, respectively) groups. First service conception rate and overall pregnancy rate did not differ (P > 0.05) between the insulin treatment group (45.4 and 63.6%) and the control group (33.3 and 40.0%). Progesterone concentration following administration of insulin increased (P < 0.05) in the insulin treated cows (2.2+/-0.4 ng/ml versus 2.9 +/- 0.4 ng/ml) but the concentration of oestradiol-17beta did not differ. The insulin concentration was higher on day 10 of the oestrous cycle (P < 0.05) in the treatment group (71.0 +/- 12.5 microU/ml versus 38.1 +/- 4.5 microU/ml). The insulin and glucose concentrations were higher (P > 0.05) in animals, which subsequently became pregnant than in non-pregnant animals. The results may indicate that there is beneficial effect of insulin on fertility in repeat breeder cattle.